Excretion of specific glycoproteins by cells infected with herpes simplex virus, types 1 and 2
Kaplan, A.S.; Erickson, J.S.; Ben-Porat, T.
Progress in Medical Virology. Fortschritte der Medizinischen Virusforschung. Progres en Virologie Medicale 21: 1-12
1975
ISSN/ISBN: 0079-645X PMID: 54930 Document Number: 94690
Document emailed within 1 workday
Related Documents
Nutter, R.L.; Rapp, F. 1973: The effect of cytosine arabinoside on virus production in various cells infected with herpes simplex virus types 1 and 2 Cancer Research 33(1): 166-170Zarling, J.M.; Moran, P.A.; Burke, R.L.; Pachl, C.; Berman, P.W.; Lasky, L.A. 1986: Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD Journal of Immunology 136(12): 4669-4673
Hill, A.B.; Barnett, B.C.; McMichael, A.J.; McGeoch, D.J. 1994: HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2 Journal of Immunology 152(6): 2736-2741
Szántó, J.; Lesso, J.; Lackovic, V. 1976: Persistent infection of BHK cells with herpes simplex virus types 1 and 2 in the absence of specific anti-herpetic antibody Acta Virologica 20(1): 40-47
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Zvonarev, A.I.; Klichko, V.I.; Shatalin, K.I.; Kuliakina, M.N.; Karaseva, E.V. 1994: The determination of the antigenic activity of recombinant virus-specific polypeptides from the herpes simplex virus types 1 and 2 and their use in immunoenzyme analysis Voprosy Virusologii 39(2): 59-62
Bruce, C.B.; Pearson, C.K. 1983: A helix-destabilising protein from herpes simplex virus type I infected cells which specifically stimulates the virus induced DNA polymerase activity in vitro Biochemical and Biophysical Research Communications 116(1): 327-334
Rajcáni, J.; Vojvodová, A. 1998: The role of herpes simplex virus glycoproteins in the virus replication cycle Acta Virologica 42(2): 103-118
Rechnio, M.; Litwińska, B.ła. 2003: Differences in inhibition of apoptosis depending on the virulence of used herpes simplex virus type 1 strains. Function of interferon alpha in apoptotic death of virus infected cells Acta Microbiologica Polonica 52(3): 271-276
Schwartz, J.; Elizan, T.S. 1975: Altered immunologic specificity of cells infected with Herpes simplex virus: recognition of human antiserum Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 148(4): 291-298
Glorioso, J.C.; Smith, J.W. 1977: Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens Journal of Immunology 118(1): 114-121
Suehiro, T. 1987: Effect of corticosteroid on IL-2 production from spleen cells of mice with corneas infected by herpes simplex virus Nippon Ganka Gakkai Zasshi 91(6): 636-642
Puthavathana, P.; Kanyok, R.; Horthongkham, N.; Roongpisuthipong, A. 1998: Prevalence of herpes simplex virus infection in patients suspected of genital herpes; and virus typing by type specific fluorescent monoclonal antibodies Journal of the Medical Association of Thailand 81(4): 260-264
Yoshida, H.; Sakata, H.; Hiyama, N.; Iwamoto, T. 1983: Effects of 5-iodo-2'-deoxyuridine on ultrastructural localization of viral antigens in cultured cells infected with herpes simplex virus Japanese Journal of Ophthalmology 27(2): 321-339
Kelman, A.D.; Gundberg, C.M.; Sinex, F.M. 1978: Repair of single-stranded breaks in host DNA when rabbit kidney cells are infected with herpes simplex virus type 2 Iarc Scientific Publications 1978(24 Part 1): 415-421
Yoosook, C.; Chantratita, W.; Rimdusit, P. 1989: Recovery frequencies of herpes simplex virus types 1 and 2 from symptomatic and asymptomatic genital herpes cases and antiviral sensitivities of isolates Journal of the Medical Association of Thailand 72(10): 572-576
Sandberg, K.; Matsson, P.; Alm, G.V. 1990: A distinct population of nonphagocytic and low level CD4+ null lymphocytes produce IFN-alpha after stimulation by herpes simplex virus-infected cells Journal of Immunology 145(3): 1015-1020
Robertson, M.W.; Wang, M.; Siegal, G.P.; Rosenfeld, M.; Ashford, R.S.; Alvarez, R.D.; Garver, R.I.; Curiel, D.T. 1998: Use of a tissue-specific promoter for targeted expression of the herpes simplex virus thymidine kinase gene in cervical carcinoma cells Cancer Gene Therapy 5(5): 331-336
Masuda, T. 1991: Immunoelectron microscopic localization of herpes simplex virus glycoprotein D in infected culture cells using the indirect peroxidase-labeled antibody method Nippon Ganka Gakkai Zasshi 95(9): 817-828